IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Zynerba Pharmaceuticals Inc

CUSIP: 98986X109 | 294 institutional holders

Quarters

Q1 2024Q3 2023Q2 2023Q1 2023Q4 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2024

B. Riley Wealth Advisors, Inc.12,732
0.0% of portfolio›$16.2K
StyleTurnoverLocationFiled
B. Riley Wealth Advisors, Inc.
12,732$16.2K0.0%GrowthLowMemphis, TN2024-05-16